Target intelligence / Profile preview

Double homeobox protein 4 like 31 (DUX4L31)

Target
DUX4L31
Molecular classification
Pseudogene
01

Overview

Double homeobox protein 4 like 31 (DUX4L31) is classified as a pseudogene in the human genome. While 'DUX4L31' is a named entity based on its sequence similarity to the functional DUX4 gene, there is no evidence that DUX4L31 encodes a functional protein or that it functions as a therapeutic target. The canonical DUX4 gene is a transcription factor involved in gene regulation during early embryogenesis and is implicated in disorders such as facioscapulohumeral muscular dystrophy. However, DUX4L31 lacks supporting evidence for protein expression or functional activity and should not be considered a validated molecular target. DUX4L31 is annotated as a pseudogene, meaning it does not encode a functional protein and lacks biological activity. There is no evidence linking DUX4L31 to molecular functions, disease roles, or drug interactions in humans. The "double homeobox" gene family (to which DUX4 and its pseudogene relatives belong) consists of transcription factors, but this functional status does not apply to DUX4L31 specifically. Information about the well-characterized DUX4 protein (not DUX4L31) includes roles in embryonic transcriptional activation, disease relevance in muscular dystrophy, and effects on translation and nuclear receptor co-repression, but these properties do not extend to the DUX4L31 pseudogene.

Other names
Double homeobox 4 like 31DUX4L31

Beyond the preview

Go deeper on Double homeobox protein 4 like 31 (DUX4L31).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Double homeobox protein 4 like 31 (DUX4L31).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call